The first patient has been dosed in the IDeate-Prostate01 phase 3 clinical trial to evaluate the efficacy and safety of investigational ifinatamab deruxtecan (I-DXd) versus docetaxel in patients with ...

IDeate-Prostate01 Phase 3 Trial of Ifinatamab Deruxtecan Initiated in Patients with Pretreated Metastatic Castration-Resistant Prostate Cancer Jun. 18, 2025 7:00 AM ET Merck & Co., Inc. (MRK), DSKYF ...

“IDeate-Prostate01 marks the initiation of the third pivotal trial in the ifinatamab deruxtecan development program and reinforces our commitment to addressing critical unmet needs for patients ...

IDeate-Prostate01 is a multicenter, open-label, randomized phase 3 trial evaluating the safety and efficacy of ifinatamab deruxtecan (12 mg/kg) versus docetaxel (75 mg/m 2) plus corticosteroid in ...

BASKING RIDGE, N.J. & RAHWAY, N.J., June 18, 2025--The first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab ...

BASKING RIDGE, N.J. & RAHWAY, N.J.-- (BUSINESS WIRE)--The first patient has been dosed in the IDeate-Prostate01 phase 3 trial evaluating the efficacy and safety of investigational ifinatamab ...

The definition of antisemitism that governments rely on may seem like a semantic debate, but the recent flurry of state legislation shows its impact on how crime data is tracked, which incidents ...

The spiritual meaning of May’s new moon is about having your heart and your head work together to open new doors, and all zodiac signs should take advantage of this special lunar moment.

IDeate-Esophageal01 is a global, multicenter, open-label, randomized phase 3 trial evaluating the safety and efficacy of ifinatamab deruxtecan (12 mg/kg) versus treatment of physician’s choice of ...

IDeate-Esophageal01 will enroll approximately 510 patients across Asia, Europe and North America. For more information, please visit ClinicalTrials.gov. About Esophageal Squamous Cell Carcinoma ...